| Lung Cancer Among Limited-Duration Former Smokers: A Predictive Model |
Wendy Leith |
Forensic Research & Analysis |
PLCO |
Mar 8, 2016 |
PLCO-195 |
| Statistical Comparison Between the Modified Logit Model and Cox Proportional Model of (PLCO) |
WISSAM AL-JANABI |
None |
PLCO |
Mar 8, 2016 |
PLCO-196 |
| Optimizing prostate cancer PSA screening through genetic profiling: Towards a personalized screening approach |
Laurent Briollais |
Lunenfeld-Tanenbaum Research Institute - Mount Sinai Hospital |
PLCO |
Mar 1, 2016 |
PLCO-194 |
| Case-cohort of oral microbiome and cancer risk |
Emily Vogtmann |
NCI |
PLCO |
Feb 10, 2016 |
2014-0191 |
| Modeling and estimating a PSA threshold for prostate cancer diagnosis |
Mei-Ling Lee |
University of Maryland |
PLCO |
Feb 3, 2016 |
PLCO-189 |
| Genome-wide association study of multiple inflammatory makers (MIP) in PLCO |
Fangyi Gu |
National Cancer Institute |
PLCO |
Feb 3, 2016 |
PLCO-191 |
| Clinical support system for lung cancer |
Sathyanarayana S |
PESIT Bangalore south campus |
PLCO |
Jan 28, 2016 |
PLCO-190 |
| Discovery and validation of computational morphologic features to predict prostate cancer recurrence (v2) |
Michael Cook |
NCI |
PLCO |
Jan 8, 2016 |
PLCO-187 |
| The interaction between genome-wide polymorphisms, progestin-use, and vitamin D intake in modifying risk of endometrial cancer |
Jason Wong |
National Cancer Institute |
PLCO |
Jan 8, 2016 |
PLCO-184 |
| Optimizing the Implementation of Novel Diagnostic Tests for Prostate, Lung, and Colon Cancer |
Grant Langseth |
OncoCellMDx |
PLCO |
Dec 29, 2015 |
PLCO-185 |
| Accuracy of self-reported colonoscopy findings |
Paul Doria-Rose |
National Cancer Institute |
PLCO |
Dec 11, 2015 |
PLCO-180 |
| Validation of Endometrial Cancer Risk Prediction Model Developed Originally in the Nurses' Health Study |
Immaculata De Vivo |
Brigham and Women’s Hospital |
PLCO |
Dec 8, 2015 |
PLCO-182 |
| Digital Rectal Exam and Prostate Cancer Screening |
Joshua Halpern |
Weill Cornell Medical College |
PLCO |
Nov 30, 2015 |
PLCO-181 |
| Rates of PSA screening in PLCO |
Jonathan Shoag |
New York Presbyterian Hospital Weill Cornell |
PLCO |
Nov 20, 2015 |
PLCO-179 |
| DRE and LUTS |
Jonathan Shoag |
NA |
PLCO |
Nov 6, 2015 |
PLCO-177 |
| Flexible Sigmoidoscopy in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: Colorectal Cancer Survival by Trial Arm |
Maryam Doroudi |
National Cancer Institute |
PLCO |
Nov 4, 2015 |
PLCO-176 |
| Improving Lung Cancer Screening Rates and Smoking Documentation through Targeted Electronic Clinical Decision Support |
Travis Osterman |
Vanderbilt University Medical Center |
PLCO |
Nov 3, 2015 |
PLCO-175 |
| Optimal endoscopy screening and surveillance intervals for colorectal cancer |
Xin Zhou |
Harvard University |
PLCO |
Nov 2, 2015 |
PLCO-174 |
| Subset Analysis of Black Men Screened on the PLCO Prostate Cancer Screening Trial |
Curtiland Deville |
Johns Hopkins University |
PLCO |
Nov 2, 2015 |
PLCO-172 |
| Examining the association between the dietary inflammatory index (DII) and pancreatic cancer risk and potential mediation by type-2 Diabetes Mellitus (DM) |
Susan Steck |
University of South Carolina |
PLCO |
Oct 23, 2015 |
PLCO-171 |
